There have been no reports of overdose with Fabrazyme. In clinical trials, patients received doses up to 3.0 mg/kg body weight. The adverse reactions experienced by patients who received treatment with 3.0 mg/kg were similar to the adverse reactions experienced by patients who received treatment with 1.0 mg/kg.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
